Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2006 | 12-2005 | |
| Sales | 43,537 | 35,075 | 0 | 0 |
| Cost of Goods | 4,137 | 3,046 | N/A | N/A |
| Gross Profit | 39,401 | 32,030 | N/A | N/A |
| Operating Expenses | 33,761 | 24,793 | 0 | 0 |
| Operating Income | 5,777 | 7,282 | N/A | N/A |
| Interest Expense | 773 | 213 | 0 | 0 |
| Other Income | 79 | 241 | 0 | 0 |
| Pre-tax Income | 5,083 | 7,310 | 0 | 0 |
| Income Tax | 2,024 | 2,544 | N/A | N/A |
| Net Income Continuous | 3,059 | 4,766 | N/A | N/A |
| Minority Interests | -33 | N/A | N/A | N/A |
| Net Income | $3,091 | $4,766 | $N/A | $N/A |
| EPS Basic Total Ops | 0.22 | 0.47 | N/A | N/A |
| EPS Basic Continuous Ops | 0.22 | 0.47 | N/A | N/A |
| EPS Diluted Total Ops | 0.17 | 0.29 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.17 | 0.29 | N/A | N/A |
| EBITDA(a) | $6,593 | $8,069 | $N/A | $N/A |